Weidong Gan

658 total citations
32 papers, 434 citations indexed

About

Weidong Gan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Weidong Gan has authored 32 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Weidong Gan's work include Renal cell carcinoma treatment (15 papers), Renal and related cancers (14 papers) and MRI in cancer diagnosis (4 papers). Weidong Gan is often cited by papers focused on Renal cell carcinoma treatment (15 papers), Renal and related cancers (14 papers) and MRI in cancer diagnosis (4 papers). Weidong Gan collaborates with scholars based in China and United States. Weidong Gan's co-authors include Hongqian Guo, Xiaogong Li, Huibo Lian, Changwei Ji, Gutian Zhang, Rong Yang, Shiwei Zhang, Xiang Yan, Xiaozhi Zhao and Wenliang Ma and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Molecular Cancer.

In The Last Decade

Weidong Gan

31 papers receiving 432 citations

Peers

Weidong Gan
Weidong Gan
Citations per year, relative to Weidong Gan Weidong Gan (= 1×) peers Fucai Tang

Countries citing papers authored by Weidong Gan

Since Specialization
Citations

This map shows the geographic impact of Weidong Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Gan more than expected).

Fields of papers citing papers by Weidong Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Gan. The network helps show where Weidong Gan may publish in the future.

Co-authorship network of co-authors of Weidong Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Gan. A scholar is included among the top collaborators of Weidong Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Gan. Weidong Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xin, Mengmeng Wu, Wenliang Ma, et al.. (2025). The Role of HADHB in Mitochondrial Fatty Acid Metabolism During Initiation of Metastasis in ccRCC. Molecular Carcinogenesis. 64(5). 923–935. 1 indexed citations
2.
Ma, Wenliang, Yi Chen, Lei Yang, et al.. (2025). TFE3 fusion proteins promote the progression of TFE3 rearranged renal cell carcinoma via enhancing chaperone-mediated lipophagy. Cell Communication and Signaling. 23(1). 122–122.
3.
Li, Xiaoxing, Yi Sui, Xiaoxiao Zhang, et al.. (2024). 442O A phase I clinical trial of intrathecal injection of allogeneic CAR-γδT cells targeting B7H3 for the treatment of patients with recurrent glioblastoma. Annals of Oncology. 35. S407–S407. 5 indexed citations
4.
Guo, Wei, et al.. (2023). Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma. Frontiers in Oncology. 13. 1116648–1116648. 4 indexed citations
5.
Liu, Ning, Yi Chen, Lei Yang, et al.. (2022). Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma. Clinical and Translational Medicine. 12(4). e797–e797. 7 indexed citations
6.
Chen, Yi, Lei Yang, Yanwen Lu, et al.. (2022). Up-regulation of NMRK2 mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma. Cancer Letters. 538. 215689–215689. 16 indexed citations
7.
Yang, Lei, Yi Chen, Ning Liu, et al.. (2022). CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3. Molecular Cancer. 21(1). 23–23. 44 indexed citations
8.
Yang, Lei, Yi Chen, Ning Liu, et al.. (2022). 5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma. Biomarker Research. 10(1). 54–54. 12 indexed citations
9.
Ma, Wenliang, Ning Liu, Weijian Li, et al.. (2020). Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: a Retrospective Multicentre Study in China. Scientific Reports. 10(1). 2249–2249. 11 indexed citations
10.
Cheng, Xiangming, et al.. (2017). Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype. Urologic Oncology Seminars and Original Investigations. 35(8). 530.e1–530.e6. 31 indexed citations
11.
Xu, Linfeng, Rong Yang, Wei Wang, et al.. (2016). Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease. World Journal of Surgical Oncology. 14(1). 193–193. 14 indexed citations
12.
Yan, Xiang, Mingxin Zhang, Wei Wang, et al.. (2015). Image-guided percutaneous renal cryoablation for stage 1 renal cell carcinoma with high surgical risk. World Journal of Surgical Oncology. 13(1). 200–200. 7 indexed citations
13.
Yang, Rong, Huibo Lian, Gutian Zhang, et al.. (2013). Laparoscopic Radiofrequency Ablation with Intraoperative Contrast-Enhanced Ultrasonography for T1bN0M0 Renal Tumors: Initial Functional and Oncologic Outcomes. Journal of Endourology. 28(1). 4–9. 13 indexed citations
14.
Yan, Xiang, et al.. (2012). Minimally invasive percutaneous nephrolithotomy in preschool age children with kidney calculi (including stones induced by melamine-contaminated milk powder). Pediatric Surgery International. 28(10). 1021–1024. 27 indexed citations
15.
Ji, Changwei, Weidong Gan, Hongqian Guo, et al.. (2012). A prospective trial on ureteral stenting combined with secondary ureteroscopy after an initial failed procedure. Urological Research. 40(5). 593–598. 20 indexed citations
16.
Lian, Huibo, Hongqian Guo, Gutian Zhang, et al.. (2012). Single-center Comparison of Complications in Laparoscopic and Percutaneous Radiofrequency Ablation With Ultrasound Guidance for Renal Tumors. Urology. 80(1). 119–125. 19 indexed citations
17.
Ji, Changwei, Xiaogong Li, Shiwei Zhang, et al.. (2011). Laparoscopic Radiofrequency Ablation of Renal Tumors: 32-Month Mean Follow-up Results of 106 Patients. Urology. 77(4). 798–802. 31 indexed citations
18.
Zhao, Xiaozhi, Wei Wang, Shiwei Zhang, et al.. (2011). Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdominal Radiology. 37(5). 885–891. 38 indexed citations
19.
Zhang, Shiwei, Xiaozhi Zhao, Changwei Ji, et al.. (2011). Radiofrequency ablation of synchronous bilateral renal cell carcinoma. International Journal of Urology. 19(3). 241–247. 11 indexed citations
20.
Guo, Hongqian, Weidong Gan, Rong Yang, et al.. (2009). UP-1.057: Laparoscopic Cool-tip Radiofrequency Ablation in Renal Angiomyolipoma. Urology. 74(4). S188–S188. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026